AFL vs OVID · P/E 14, rev $4.12B vs rev $733.0K
Aflac Incorporated (AFL) versus Ovid Therapeutics Inc (OVID) — a side-by-side from cached financials, not a winner call.
Aflac Incorporated (AFL) is a insurance - life company listed on US.
Ovid Therapeutics Inc (OVID) is a biotechnology company listed on US.
Latest reported AFL revenue for 2026-06-30 was $4.12B. Net income was $825.0M. Revenue was down 5.3% from 2026-03-31 to 2026-06-30. AFL currently screens at market cap $60.18B and trailing P/E 13.5.
Latest reported OVID revenue for 2026-06-30 was $733.0K. Net income was -$32.0M. OVID currently screens at market cap $23.5M.
AFL currently screens at market cap $60.18B and trailing P/E 13.5. OVID currently screens at market cap $23.5M.
Not investment advice. Open the AFL and OVID stock pages for the full models.
Not investment advice.